Newsroom
Latest Biotechnology News
News releases related to the Biotechnology industry.
-
World Class Retains Mackie Research Capital for Capital Markets ServicesToronto, Ontario--(Newsfile Corp. - April 18, 2019) - World Class Extractions Inc. (CSE: PUMP) ("World Class" or the "Company") is pleased to announce that it has retained the services of Mackie Research Capital Corporation ("Mackie Research") to act as financial advisor to the Company. Mackie Research will provide advisory ...
Biotechnology, Cannabis
2019-04-18 8:30 AM ET | World Class Extractions Inc. -
PreveCeutical Partnership Leads to Two New Patent FilingsVancouver, British Columbia--(Newsfile Corp. - April 17, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that the Company's research collaboration with UniQuest and The University of Queensland ("UQ") has led to the filing of two new patent applications for cyclic peptides ...
Biotechnology, Medical/Pharmaceuticals
2019-04-17 10:35 AM ET | PreveCeutical Medical Inc. -
PreveCeutical Files Application to Human Ethics Committee to Acquire Human Tissue for the Final Phase of the Sol-Gel Program
Vancouver, British Columbia--(Newsfile Corp. - April 15, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces the Company's research team at the University of Queensland has filed an application to a local hospital's Human Ethics Committee (the "Human Ethics Committee") to acquire ...
Biotechnology, Medical/Pharmaceuticals
2019-04-15 8:30 AM ET | PreveCeutical Medical Inc. -
Genprex Featured in NetworkNewsAudio Broadcast on Potential Gene Therapy Treatment for CancerNew York, New York--(Newsfile Corp. - April 12, 2019) - Genprex Inc. (NASDAQ: GNPX) announces the availability of a NetworkNewsAudio broadcast titled, "Potential Blockbuster Gene Therapy Programs to Watch in 2019."To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/j1WMsTo read the full editorial, visit:
Biotechnology, Health Care/Hospitals
2019-04-12 9:00 AM ET | Genprex, Inc. -
Genprex (GNPX) Featured in NetworkNewsWire Publication about Revolutionary Gene Therapies
New York, New York--(Newsfile Corp. - April 11, 2019) - Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities.To view the full publication, titled "Potential Blockbuster Gene Therapy Programs to Watch in ...
Biotechnology, Health Care/Hospitals
2019-04-11 8:30 AM ET | Genprex, Inc. -
In a Major Breakthrough, Q BioMed Discovers First Biomarkers for Pediatric Nonverbal Autism SubgroupMarks the first time a company has identified biomarkers that hold the potential to stratify this subset of patientsStudy examined 1,953 significant autistic biomarkers, resulting in 2 significant markers tied to expressed genes and pathways responsible for speech developmentBiomarkers in the nonverbal subset were distinct from children with typical speech ...
Biotechnology
2019-04-10 8:30 AM ET | Q BioMed Inc. -
PreveCeutical Announces Further Results from its Preliminary Screening of Peptides Derived from Blue Scorpion Venom in a Cell-Based Brain Cancer Model
Vancouver, British Columbia--(Newsfile Corp. - April 10, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce further positive results from the preliminary screening of key peptides from its scorpion venom-derived peptide research and development program (the "Peptide Program"), that is ...
Biotechnology, Medical/Pharmaceuticals
2019-04-10 8:30 AM ET | PreveCeutical Medical Inc. -
PreveCeutical Announces Default Judgment Against JCN Capital Corp.
Vancouver, British Columbia--(Newsfile Corp. - April 8, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that it has obtained a default judgement against JCN Capital Corp. ("JCN") in connection with a Supreme Court of British Columbia action (the "Action"). The Action ...
Biotechnology, Medical/Pharmaceuticals
2019-04-08 9:35 AM ET | PreveCeutical Medical Inc. -
Retraction to News Release dated April 4, 2019
Vancouver, British Columbia--(Newsfile Corp. - April 4, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, at the request of the Investment Industry Regulatory Organization of Canada, it hereby retracts certain statements regarding estimated annual production, valuation and harvest quantities from the ...
Biotechnology, Medical/Pharmaceuticals
2019-04-04 5:09 PM ET | PreveCeutical Medical Inc. -
Asterion Welcomes Australian Government Awarding of Major Project Status for its Toowoomba Medicinal Cannabis Project
Vancouver, British Columbia--(Newsfile Corp. - April 4, 2019) - Asterion Cannabis Inc. (P.ASTR) ("Asterion") and PreveCeutical Medical Inc. ("PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), announce today that Asterion's wholly-owned Australian subsidiary, Asterion Australia Pty Ltd, has been awarded Major Project Status for Asterion's Toowoomba Medicinal Cannabis Project (the "Toowoomba ...
Biotechnology, Medical/Pharmaceuticals
2019-04-04 2:40 PM ET | PreveCeutical Medical Inc. -
Genprex Featured in NetworkNewsAudio Publication on Unprecedented Targeting in Cancer Treatment
New York, New York--(Newsfile Corp. - March 29, 2019) - Genprex Inc. (NASDAQ: GNPX) announces the availability of a NetworkNewsAudio publication titled, "Advanced Medical Technologies Provides Unprecedented Targeting in Cancer Therapy."To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/XRt4dTo read the full editorial, visit:
Biotechnology, Health Care/Hospitals
2019-03-29 9:00 AM ET | Genprex, Inc. -
Genprex Featured in NetworkNewsWire Publication on Innovations in Cancer Therapy
New York, New York--(Newsfile Corp. - March 28, 2019) - Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities.To view the full publication, titled "Advanced Medical Technologies Provides Unprecedented Targeting in ...
Biotechnology, Health Care/Hospitals
2019-03-28 8:30 AM ET | Genprex, Inc. -
Biotechnology Accelerator Positions Multiple Shots on Goal in the Multi-Billion Dollar Glaucoma Market with Commercialization Target in the Near TermNew York, New York--(Newsfile Corp. - March 27, 2019) - "In the near-term, Q BioMed Inc. (OTCQB: QBIO) has multiple shots on goal with respect to market share, revenue and profit in the multi-billion dollar glaucoma market," says former Piper Jaffray analyst and mutual fund manager Rob Goldman, who now ...
Biotechnology
2019-03-27 9:20 AM ET | Q BioMed Inc. -
PreveCeutical Announces Default Judgment Against Essos Corporate Services Inc. and Detona Capital Corp.
Vancouver, British Columbia--(Newsfile Corp. - March 25, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that it has obtained a default judgement against each of Essos Corporate Services Inc. ("Essos") and Detona Capital Corp. ("Detona") in connection with a Supreme Court of ...
Biotechnology, Medical/Pharmaceuticals
2019-03-25 8:00 AM ET | PreveCeutical Medical Inc. -
Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster University
Enabling technology to more effectively manage glaucoma progression and patient treatmentServes unmet need - Currently no single examination or diagnostic test is able to accurately predict disease progressionSimple diagnostic test that can be performed at a physician's office with no external expensive equipmentNew York, New York--(Newsfile Corp. - March 19, ...
Biotechnology
2019-03-19 7:00 AM ET | Q BioMed Inc. -
Biocure Announces the Appointment of a New DirectorVancouver, British Columbia--(Newsfile Corp. - March 14, 2019) - Biocure Technology Inc. (CSE: CURE) (OTCQB: BICTF) ("CURE" or the "Company") is pleased to announce that effective of today's date, Mr. Danny Joh has been appointed as a director of Biocure Technology Inc.After completing a PhD in Biochemistry at Texas A&M ...
Biotechnology, Medical/Pharmaceuticals
2019-03-14 9:00 AM ET | Biocure Technology Inc. -
Rapid Dose Therapeutics and Thrive Cannabis Sign MOU to Provide Quickstrip(TM) Oral Thin Strips Under a White Label Manufacturing AgreementBurlington, Ontario--(Newsfile Corp. - March 13, 2019) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian bio-technology company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed a Memorandum of Understanding ("MOU") February 27, 2019 with THRIVE Cannabis ...
Biotechnology
2019-03-13 8:31 AM ET | Rapid Dose Therapeutics Corp. -
Sona Nanotech Inc. Signs Agreement to Develop Innovative New Point of Care Tests for Infectious DiseasesHalifax, Nova Scotia--(Newsfile Corp. - March 12, 2019) - Sona Nanotech Inc. (CSE: SONA) has signed a collaboration agreement with a UK medical diagnostics company to develop new highly sensitive point of care diagnostic tests for infectious diseases.OLM Diagnostics, based in Newcastle Upon Tyne, England, manufactures, markets and distributes innovations ...
Biotechnology, Medical/Pharmaceuticals
2019-03-12 8:30 AM ET | Sona Nanotech Inc. -
PreveCeutical Announces Preliminary Screening Results of Peptides Derived From Blue Scorpion Venom in a Cell-Based Brain Cancer Model
Vancouver, British Columbia--(Newsfile Corp. - March 11, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce positive results from the preliminary screening of key peptides from its scorpion venom-derived peptide research and development program (the "Peptide Program"), that is expected to enable ...
Biotechnology, Medical/Pharmaceuticals
2019-03-11 9:00 AM ET | PreveCeutical Medical Inc. -
Rapid Dose Therapeutics Corp. Grants Stock Options
Burlington, Ontario--(Newsfile Corp. - March 11, 2019) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Corporation") announces the grant of options to directors, officers, eployess and consultants to purchase 4,526,000 common shares of the Corporation, exercisable at $0.82 per share at any time on or before March 11, ...
Biotechnology
2019-03-11 8:31 AM ET | Rapid Dose Therapeutics Corp. -
Q BioMed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression from Washington University
New York, New York--(Newsfile Corp. - March 11, 2019) - Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration development company, is pleased to announce it has exercised its option to exclusively license GDF15, a diagnostic marker for determining the severity of glaucoma using the expression levels of Growth Differentiation ...
Biotechnology
2019-03-11 8:30 AM ET | Q BioMed Inc. -
Abattis Announces Resignation of DirectorsVancouver, British Columbia--(Newsfile Corp. - March 9, 2019) - Abattis Bioceuticals Corp (CSE: ATT) (OTC Pink: ATTBF) (the "Company" or "Abattis") announces that, effective February 20, 2019 and March 6, 2019, both Wolfgang Richter and James Irving have respectively resigned as directors of the Company.The Company thanks both Mr. ...
Biotechnology, Cannabis
2019-03-09 12:00 PM ET | Abattis Bioceuticals Corp. -
Sona Nanotech Announces Collaboration with Leading Diagnostic Company to Improve Performance of Foodborne Pathogen Tests
Halifax, Nova Scotia--(Newsfile Corp. - March 7, 2019) - Sona Nanotech Inc. (CSE: SONA) today announced a collaboration with global diagnostics solutions provider Romer Labs to improve performance in their RapidChek® SELECT™ pathogen test kits.With over 30 years of experience in this field, and labs in Austria, UK, US ...
Biotechnology, Medical/Pharmaceuticals
2019-03-07 9:30 AM ET | Sona Nanotech Inc. -
Rapid Dose Therapeutics Wins Summary Judgment Against CTT Pharmaceuticals. CTT's Case Is Dismissed
Burlington, Ontario--(Newsfile Corp. - March 5, 2019) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian bio-technology company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has been successful in obtaining a summary judgment against CTT Pharmaceutical Holdings, Inc. ("CTT") ...
Biotechnology
2019-03-05 6:38 PM ET | Rapid Dose Therapeutics Corp. -
Calyx Announces Upgrade of LeafHub PlatformVancouver, British Columbia--(Newsfile Corp. - March 5, 2019) - Calyx Ventures Inc. (TSXV: CYX) ("Calyx" or the "Company") is pleased to announce the redesign and upgrade of its LeafHub platform. Through LeafHub, Calyx's wholly-owned subsidiary, Cannigistics Agri-Solutions Corp., has built a fully integrated cannabis and hemp online portal which ...
Biotechnology
2019-03-05 9:00 AM ET | Calyx Ventures Inc.